Womb Stem Cell Therapy Repairs Severe Birth Defect, Trial Shows
In a remarkable medical breakthrough, stem cell therapy administered to babies while still in the womb has successfully reversed brain abnormalities associated with spina bifida, a severe birth defect characterised by incomplete spinal development. This pioneering approach, detailed in a recent trial, offers transformative potential for altering the lifelong health outcomes of affected individuals.
Groundbreaking Foetal Surgery Procedure
During the innovative foetal surgery, surgeons directly applied stem cells, which were carefully derived from donated placentas, to the exposed spinal cord of the foetus. This targeted intervention aimed to address the critical neural issues linked to spina bifida, specifically myelomeningocele and hindbrain herniation—a brain abnormality that often accompanies the condition.
Successful Outcomes in California Trial
The trial, conducted in California, involved six women who were between 24 and 25 weeks pregnant, each carrying a baby diagnosed with myelomeningocele and hindbrain herniation. The results were highly encouraging:
- All six babies were born with intact spinal repairs, showing no signs of infection.
- MRI scans conducted after birth confirmed that the hindbrain herniation had been completely reversed.
- One notable case involves a toddler, born with spina bifida after undergoing this in-womb surgery, who is now actively learning how to walk—a milestone that underscores the procedure's effectiveness.
Implications for Future Health and Research
Researchers involved in the trial are optimistic about the long-term benefits, suggesting that this stem cell therapy could significantly alter the health trajectory of individuals with spina bifida. The positive findings have already paved the way for an expanded study, which will now include 35 patients to further validate and refine the technique.
This advancement not only highlights the potential of regenerative medicine but also opens new avenues for treating severe congenital conditions before birth, potentially reducing lifelong disabilities and improving quality of life.
